These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 7042481)

  • 21. [Atenolol: its effects on pressure in open-angle glaucoma].
    Collignon-Brach J; Weekers R
    J Fr Ophtalmol; 1978 Mar; 1(3):205-9. PubMed ID: 659804
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The comparative multiple-dose intraocular pressure responses of nadolol and timolol in glaucoma and ocular hypertension.
    Krieglstein GK; Mohamed J
    Acta Ophthalmol (Copenh); 1982 Apr; 60(2):284-92. PubMed ID: 6127861
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intraocular pressure reduction during treatment with pilocarpine and systemic propranolol. A comparative double-masked study.
    Wettrell K
    Albrecht Von Graefes Arch Klin Exp Ophthalmol; 1977 Sep; 204(1):1-7. PubMed ID: 335912
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reduction of intraocular pressure with treatment of latanoprost once daily in patients with normal-pressure glaucoma.
    Rulo AH; Greve EL; Geijssen HC; Hoyng PF
    Ophthalmology; 1996 Aug; 103(8):1276-82. PubMed ID: 8764799
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of atenolol and oxprenolol in the treatment of arterial hypertension. A comparison.
    Turner AS; Watson OF; Brocklehurst JE
    Med J Aust; 1979 Jun; 1(13):625-6. PubMed ID: 386061
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early dose response analysis of ocular hypotensive effects of propranolol in patients with ocular hypertension.
    Wettrell K; Pandolfi M
    Br J Ophthalmol; 1976 Oct; 60(10):680-3. PubMed ID: 795456
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Comparative study of atenolol and timolol in the treatment of ocular hypertension].
    Collignon-Brach J; Weekers R
    Bull Soc Belge Ophtalmol; 1978; (180):21-6. PubMed ID: 373834
    [No Abstract]   [Full Text] [Related]  

  • 28. Metoprolol and atenolol administered once daily in primary hypertension. A clinical comparison of the efficacy of two selective beta-adrenoceptor blocking agents.
    Lyngstam O; Rydén L
    Acta Med Scand; 1981; 209(4):261-6. PubMed ID: 7015797
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and safety of bisoprolol and atenolol in patients with mild to moderate hypertension: a double-blind, parallel group international multicentre study.
    Lithell H; Selinus I; Hosie J; Frithz G; Weiner L
    Eur Heart J; 1987 Dec; 8 Suppl M():55-64. PubMed ID: 2967186
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of metoprolol on intra-ocular pressure in glaucoma. A pilot study.
    Alm A; Wickström CP; Eckström C; Ohman L
    Acta Ophthalmol (Copenh); 1979 Apr; 57(2):236-42. PubMed ID: 452883
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of glaucoma with atenolol eye drops.
    Dhir SP; Sharma PL; Jain IS
    Indian J Ophthalmol; 1981 Oct; 29(3):229-33. PubMed ID: 7346433
    [No Abstract]   [Full Text] [Related]  

  • 32. Effects of atenolol and propranolol when added to long-term antihypertensive diuretic therapy.
    van Rooijen GJ; Boer P; Dorhout Mees EJ; Geyskes GG
    Clin Pharmacol Ther; 1979 Oct; 26(4):420-7. PubMed ID: 487688
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of Topical Bimatoprost 0.01% and Timolol 0.5% on Circadian IOP, Blood Pressure and Perfusion Pressure in Patients with Glaucoma or Ocular Hypertension: A Randomized, Double Masked, Placebo-Controlled Clinical Trial.
    Oddone F; Rossetti L; Tanga L; Berardo F; Ferrazza M; Michelessi M; Roberti G; Manni G; Centofanti M
    PLoS One; 2015; 10(10):e0140601. PubMed ID: 26484767
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Atenolol as primary therapy in previously untreated hypertensives and as an adjuvant to other therapy. A South African Multicentre Study.
    Cilliers AJ
    S Afr Med J; 1979 Mar; 55(9):321-4. PubMed ID: 375435
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Levobunolol and betaxolol. A double-masked controlled comparison of efficacy and safety in patients with elevated intraocular pressure.
    Long DA; Johns GE; Mullen RS; Bowe RG; Alexander D; Epstein DL; Weiss MJ; Masi RJ; Charap AD; Eto CY
    Ophthalmology; 1988 Jun; 95(6):735-41. PubMed ID: 3062529
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The long-term ocular and systemic effects of topically applied metoprolol tartrate in glaucoma and ocular hypertension.
    Krieglstein GK
    Acta Ophthalmol (Copenh); 1981 Feb; 59(1):15-20. PubMed ID: 7010891
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Timolol and metoprolol in glaucoma. A comparison of the ocular hypotensive effect, local and systemic tolerance.
    Nielsen NV; Eriksen JS
    Acta Ophthalmol (Copenh); 1981 Jun; 59(3):336-46. PubMed ID: 7034454
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term hypotensive effect of atenolol 4% eyedrops.
    Brenkman RF
    Br J Ophthalmol; 1978 May; 62(5):287-91. PubMed ID: 656355
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of Topically Administered Rho-Kinase Inhibitor AR-12286 in Patients With Exfoliation Syndrome and Ocular Hypertension or Glaucoma.
    Skaat A; Jasien JV; Ritch R
    J Glaucoma; 2016 Sep; 25(9):e807-14. PubMed ID: 27552517
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Switching from latanoprost to fixed-combination latanoprost-timolol: a 21-day, randomized, double-masked, active-control study in patients with glaucoma and ocular hypertension.
    Olander K; Zimmerman TJ; Downes N; Schoenfelder J;
    Clin Ther; 2004 Oct; 26(10):1619-29. PubMed ID: 15598478
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.